Open AccessMAB_2355c Confers Macrolide Resistance in Mycobacterium abscessus by Ribosome Protection
Author(s) -
Qi Guo,
Yongjie Zhang,
Junsheng Fan,
Haonan Zhang,
Zhemin Zhang,
Bing Li,
Haiqing Chu
Publication year - 2021
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00330-21
Subject(s) - complementation , mycobacterium abscessus , biology , ribosome , microbiology and biotechnology , monoclonal antibody , mycobacterium , gene , biochemistry , mutant , genetics , rna , bacteria , antibody
Macrolide resistance is always a concern when treatingMycobacterium abscessus infections. MAB_2355c was identified previously as a possible new factor that confers the intrinsic resistance of 194 clinicalM. abscessus isolates to clarithromycin.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom